CNBC: Black health leaders try to build trust in the COVID-19 vaccine among African Americans
Louito Edje, MD, wants to inspire confidence in COVID-19 vaccine
African-American health professionals and community health groups across the country have already begun to do outreach in Black communities hit hard by the coronavirus.
Seven out of 10 African Americans know someone who’s been hospitalized or died from COVID-19, according to a Pew Research poll conducted last month. Yet vaccine skepticism runs high. Only 42% of Blacks surveyed say they plan to be vaccinated, compared with more than 60% for Americans overall.
The vaccine is almost here, but we can't get to a new normal if people don't take the shot. According to a Pew survey, only about 60% of Americans say they'll get the vaccine. However, only 42% of black adults say they'll get it.
— The News with Shepard Smith (@thenewsoncnbc) December 11, 2020
CNBC's @berthacoombs has the story. pic.twitter.com/WvdTOyUPIg
Louito Edje, MD, associate dean of graduate medical education at the UC College of Medicine and UC Medical Center, enrolled in the Phase 3 clinical trial for SARS-CoV-2 vaccine after three of her relatives died from the coronavirus. UC is one of approximately 90 sites in the country to host a trial for the mRNA-1273 vaccine developed by the National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
Edje holds a master's of health professions education and is a fellow of the American Academy of Family Physicians. She wanted to set an example and inspire confidence in her patients to get vaccinated. Edje shared her story with CNBC as part of a segment including interviews from health professionals across the country and community groups promoting vaccination against COVID-19. “I felt that I might be able to have an impact that has some credibility, for the patients that I take care of every day who look just like me,” Edje told CNBC.
Learn more about Dr. Edje online.
Featured image with Louito Edje, MD, in front of the UC College of Medicine by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.